EPIMS
TEVA icon

Evelyn Partners Investment Management Services’s Teva Pharmaceuticals TEVA Stock Holding History

Evelyn Partners Investment Management Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.5K Hold
480
– – ﹤0.01% 241
2025
Q4 		$15K Hold
480
– – ﹤0.01% 221
2025
Q3 		$9.7K Hold
480
– – ﹤0.01% 236
2025
Q2 		$8.04K Hold
480
– – ﹤0.01% 231
2025
Q1 		$7.38K Hold
480
– – ﹤0.01% 234
2024
Q4 		$10.6K Buy
+480
New +$8.73K ﹤0.01% 229

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Evelyn Partners Investment Management Services's TEVA Position: Q1 2026 in Review

Evelyn Partners Investment Management Services held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 480 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Evelyn Partners Investment Management Services first reported a position in TEVA in Q4 2024 and has held it in 6 quarters since. The position peaked at $15K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Evelyn Partners Investment Management Services held 480 shares of Teva Pharmaceuticals worth $14.5K as of Q1 2026.
  • Evelyn Partners Investment Management Services left its Teva Pharmaceuticals share count unchanged in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #241 holding.
  • Evelyn Partners Investment Management Services first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management Services's Teva Pharmaceuticals position peaked at $15K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.